Elios Biotechnology (Shanghai)
Focusing on the development and application of technical products for pharmaceutical process technology, and is committed to providing pharmaceutical companies with high-quality separation and purification solutions that meet the requirements of domestic and foreign regulations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
* | CNY100m | Series A | |
| Total Funding | 000k | ||
Related Content
Elios Biotechnology (Shanghai) Co., Ltd., also known as Alioth Biotech, is a company focused on the development and application of filtration-based products and technologies for pharmaceutical processing. Founded in Shanghai in 2021, the company provides life science solutions that are compliant with regulatory standards, enabling its pharmaceutical and biotechnology partners to develop and manufacture a range of therapies. The company's product portfolio includes cartridge filters and depth filters, such as the Alidep® Depth Filter, which are primarily used for the clarification of monoclonal antibodies and recombinant proteins. Alioth Biotech also has a focus on novel treatments, including cell and gene therapy, and provides validation services to support its clients.
To further its growth, the company has secured financing for the construction of a membrane research and development center and for the expansion of its production capabilities for filter products. This investment will support the company's goal of providing high-quality separation and purification solutions to the pharmaceutical industry.
Keywords: pharmaceutical processing, filtration technology, monoclonal antibodies, recombinant proteins, cell & gene therapy, life sciences, bioprocessing, depth filters, validation services, biotechnology